Literature DB >> 24188450

Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model.

Haixue Kuang1, Dongwei Han, Jiaming Xie, Yongxin Yan, Ji Li, Pengling Ge.   

Abstract

Premature ovarian failure (POF) contributes to amenorrhoea, infertility, early onset of menostasia and osteoporosis. This study profiled differentially expressed miRNAs for association with POF development. Ovarian tissue samples from 4-vinylcyclohexene diepoxide (VCD)-induced rat POF and normal rats were profiled for differentially expressed miRNAs using miRNA microarrays. A total of 63 miRNAs were up-regulated and 20 miRNAs were down-regulated in rat POF tissues versus the control tissues. qRT-PCR verified some of these altered miRNAs, i.e. miR-29a and miR-144 were down-regulated in POF tissues, which may target expression of PLA2G4A that is involved in prostaglandin biosynthesis, whereas miR-27b and miR-190 were up-regulated in POF tissues by negative control of PAPPA and CCL2 expression, respectively, both of which have been shown to relate to response to hormone stimulus. Moreover, the up-regulated miR-151 and miR-672 can also target expression of TNFSF10 and FNDC1, which have been shown to positively regulate cell apoptosis. Profiling of differentially expressed miRNAs in POF provided a novel insight into the molecular events involving the role of miRNAs in POF development with specific emphasis upon miR-27b, miR-190, miR-151, miR-672, miR-29a and miR-144.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24188450     DOI: 10.3109/09513590.2013.850659

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  17 in total

Review 1.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

2.  Genome-scale transcriptional analysis reveals key genes associated with the development of type II diabetes in mice.

Authors:  Yuchi Zhang; Dongwei Han; Pengyang Yu; Qijing Huang; Pengling Ge
Journal:  Exp Ther Med       Date:  2017-01-13       Impact factor: 2.447

3.  Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying MicroRNA-29a Improves Ovarian Function of Mice with Primary Ovarian Insufficiency by Targeting HMG-Box Transcription Factor/Wnt/β-Catenin Signaling.

Authors:  Tian Gao; Yi Cao; Min Hu; Ying Du
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

Review 4.  Genetics of primary ovarian insufficiency: a review.

Authors:  Cristina Fortuño; Elena Labarta
Journal:  J Assist Reprod Genet       Date:  2014-09-18       Impact factor: 3.412

Review 5.  The role of miRNAs in regulating adrenal and gonadal steroidogenesis.

Authors:  Salman Azhar; Dachuan Dong; Wen-Jun Shen; Zhigang Hu; Fredric B Kraemer
Journal:  J Mol Endocrinol       Date:  2020-01       Impact factor: 5.098

6.  American ginseng regulates gene expression to protect against premature ovarian failure in rats.

Authors:  Lei Zhu; Ji Li; Nannan Xing; Dongwei Han; Haixue Kuang; Pengling Ge
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 7.  Genetics of the ovarian reserve.

Authors:  Emanuele Pelosi; Antonino Forabosco; David Schlessinger
Journal:  Front Genet       Date:  2015-10-15       Impact factor: 4.599

Review 8.  Premature Ovarian Insufficiency - an update on recent advances in understanding and management.

Authors:  Saioa Torrealday; Pinar Kodaman; Lubna Pal
Journal:  F1000Res       Date:  2017-11-29

9.  Changes of Ovarian microRNA Profile in Long-Living Ames Dwarf Mice during Aging.

Authors:  Augusto Schneider; Scot J Matkovich; Berta Victoria; Lina Spinel; Andrzej Bartke; Pawel Golusinski; Michal M Masternak
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

Review 10.  MicroRNAs in ovarian function and disorders.

Authors:  Ying Li; Ying Fang; Ying Liu; Xiaokui Yang
Journal:  J Ovarian Res       Date:  2015-08-01       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.